11-626984-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021920.4(SCT):c.77G>A(p.Arg26Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000305 in 1,277,722 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_021920.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCT | NM_021920.4 | c.77G>A | p.Arg26Gln | missense_variant | 2/4 | ENST00000176195.4 | NP_068739.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCT | ENST00000176195.4 | c.77G>A | p.Arg26Gln | missense_variant | 2/4 | 1 | NM_021920.4 | ENSP00000176195.3 |
Frequencies
GnomAD3 genomes AF: 0.0000635 AC: 9AN: 141718Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000658 AC: 8AN: 121536Hom.: 0 AF XY: 0.0000748 AC XY: 5AN XY: 66862
GnomAD4 exome AF: 0.0000264 AC: 30AN: 1136004Hom.: 0 Cov.: 33 AF XY: 0.0000233 AC XY: 13AN XY: 557124
GnomAD4 genome AF: 0.0000635 AC: 9AN: 141718Hom.: 0 Cov.: 32 AF XY: 0.0000436 AC XY: 3AN XY: 68790
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.77G>A (p.R26Q) alteration is located in exon 2 (coding exon 2) of the SCT gene. This alteration results from a G to A substitution at nucleotide position 77, causing the arginine (R) at amino acid position 26 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at